These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 25084633)
41. Meta-analysis of randomized control trials applied to cancer therapy. Chalmers TC; Lau J Important Adv Oncol; 1992; ():235-41. PubMed ID: 1582675 [No Abstract] [Full Text] [Related]
42. Reasons or excuses for avoiding meta-analysis in forest plots. Ioannidis JP; Patsopoulos NA; Rothstein HR BMJ; 2008 Jun; 336(7658):1413-5. PubMed ID: 18566080 [TBL] [Abstract][Full Text] [Related]
43. Beyond the forest plot: The drapery plot. Rücker G; Schwarzer G Res Synth Methods; 2021 Jan; 12(1):13-19. PubMed ID: 32336044 [TBL] [Abstract][Full Text] [Related]
44. [Basic concepts in epidemiology and statistics for reading controlled clinical trials]. Coutinho ES; Cunha GM Braz J Psychiatry; 2005 Jun; 27(2):146-51. PubMed ID: 15962142 [TBL] [Abstract][Full Text] [Related]
45. "Large-scale randomized evidence: large, simple trials and overviews of trials": discussion. A clinician's perspective on meta-analyses. Horwitz RI J Clin Epidemiol; 1995 Jan; 48(1):41-4. PubMed ID: 7853046 [No Abstract] [Full Text] [Related]
46. A word from our moderator. Shrier I JAMA; 2007 Jan; 297(2):156-7; author reply 157. PubMed ID: 17213397 [No Abstract] [Full Text] [Related]
47. A word from our moderator. Deinum J; van der Wilt GJ JAMA; 2007 Jan; 297(2):156; author reply 157. PubMed ID: 17213398 [No Abstract] [Full Text] [Related]
48. [Subgroup analysis and forest plots: Limitations and interests]. Filleron T; Gilhodes J; Delord JP; Cabarrou B Bull Cancer; 2017 Jan; 104(1):92-100. PubMed ID: 27823809 [TBL] [Abstract][Full Text] [Related]
50. Metaanalytic revision of endpoints. Gallagher EJ Ann Emerg Med; 1999 Jul; 34(1):91-5. PubMed ID: 10382000 [No Abstract] [Full Text] [Related]
51. The nature of truth: Simpson's Paradox and the limits of statistical data. Heydtmann M QJM; 2002 Apr; 95(4):247-9. PubMed ID: 11937652 [No Abstract] [Full Text] [Related]
52. Trials and tribulations of a meta-analyst. Choi SW; Lam DM Anaesthesia; 2016 Feb; 71(2):228-31. PubMed ID: 26617398 [No Abstract] [Full Text] [Related]
53. How to interpret meta-analysis models: fixed effect and random effects meta-analyses. Nikolakopoulou A; Mavridis D; Salanti G Evid Based Ment Health; 2014 May; 17(2):64. PubMed ID: 24778439 [TBL] [Abstract][Full Text] [Related]
54. Missing the trees for the forest: most subgroup analyses using forest plots at the ASCO annual meeting are inconclusive. Hahn AW; Dizman N; Msaouel P Ther Adv Med Oncol; 2022; 14():17588359221103199. PubMed ID: 35677319 [TBL] [Abstract][Full Text] [Related]
55. Hypothetical Outcome Plots Outperform Error Bars and Violin Plots for Inferences about Reliability of Variable Ordering. Hullman J; Resnick P; Adar E PLoS One; 2015; 10(11):e0142444. PubMed ID: 26571487 [TBL] [Abstract][Full Text] [Related]
56. Data discrepancies in meta-analyses that use standarized mean differences. McGuire H; Edmonds M; Price J JAMA; 2007 Nov; 298(19):2261-2; author reply 2262-3. PubMed ID: 18029827 [No Abstract] [Full Text] [Related]